Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Merkel cell carcinoma].

G Viola1, P Visca, S Bucher

  • 1Istituto Nazionale Tumori "Regina Elena", Roma, Italia.

La Clinica Terapeutica
|January 19, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Merkel-cell carcinoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up.

ESMO open·2024
Same author

Effects of pioglitazone on the differentiation and inflammation in vitiligo keratinocytes.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Hybrid cooperative complexes to decrease VAS score and enhance sexual function in women with vulvar lichen sclerosus.

European review for medical and pharmacological sciences·2024
Same author

Constraints on upper crustal fluid circulation and seismogenesis from in-situ outcrop quantification of complex fault zone permeability.

Scientific reports·2023
Same author

Withdrawal of active treatments in terminally ill heart failure patients.

International journal of cardiology·2021
Same author

Impact of ablation index settings on pulmonary vein reconnection.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2021
Same journal

Effectiveness of Focal Muscle Vibration in Post-Anterior Cruciate Ligament Reconstruction Rehabilitation: A Case Report.

La Clinica terapeutica·2026
Same journal

Violence Against Women as a Public-Health Exposure: Biological Embedding, Medico-Legal Caution and Precision Prevention in the EpiWe Framework.

La Clinica terapeutica·2026
Same journal

Suicide of the Work-Disabled Individual Affected by Neoplasia with Unfavorable Prognosis: Evidence-Based Legal Medicine in Reconstructing the Causal Link.

La Clinica terapeutica·2026
Same journal

The therapeutic potential of N-acetylcysteine across multiple organ systems: a narrative review.

La Clinica terapeutica·2026
Same journal

Mesotherapy in Pain Management in Primary Care: A Narrative Review and Practice-Oriented Appraisal.

La Clinica terapeutica·2026
Same journal

Bone Marrow Edema in Rheumatic Diseases: Incidence, Diagnosis, and Therapeutic Implications. A Narrative Review.

La Clinica terapeutica·2026
See all related articles

Merkel cell carcinoma, a rare neuroendocrine skin cancer, is aggressive. Treatment depends on stage, with surgery and radiation for non-metastatic disease and chemotherapy for advanced cases.

Area of Science:

  • Oncology
  • Dermatology
  • Neuroendocrinology

Background:

  • Merkel cell carcinoma (MCC) is a rare, aggressive skin cancer of neuroendocrine origin.
  • Primarily affects sun-exposed areas in fair-skinned individuals.
  • Survival is strongly correlated with the stage at diagnosis.

Purpose of the Study:

  • To review current diagnostic and treatment strategies for Merkel cell carcinoma.
  • To present findings from a small cohort of MCC patients.
  • To compare treatment outcomes with existing literature.

Main Methods:

  • Review of staging evaluations including CT and PET scans.
  • Description of standard treatment for non-metastatic MCC: surgical excision and radiotherapy.
  • Overview of chemotherapy regimens used for metastatic MCC, including CAV and etoposide-cisplatin/carboplatin.

Related Experiment Videos

Main Results:

  • Standard treatment for non-metastatic MCC involves surgery and potentially radiotherapy.
  • Chemotherapy regimens like CAV (75% response) and etoposide/platinum (60% response) show efficacy in metastatic MCC.
  • Limited data exists for other agents; targeted therapies show preliminary promise.

Conclusions:

  • Treatment for MCC is stage-dependent, with surgery and radiation as standard for non-metastatic disease.
  • Chemotherapy is crucial for metastatic MCC, with established regimens showing significant response rates.
  • Further research into targeted agents is warranted for advanced MCC.